Rapport Therapeutics Financial Ratios for Analysis 2022-2024 | RAPP

Fifteen years of historical annual and quarterly financial ratios and margins for Rapport Therapeutics (RAPP).

Annual Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
20232022
17.1418.80
--
--
--
--
--
--
--
--
--
--
--
--
136106
-24.68-54.61
-22.38-33.71
-24.68-54.61
33.795.44
-18.05-4.17
-19.13-4.54

Quarterly Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
2024-09-302024-06-302023-12-312023-09-302023-06-302022-12-31
45.9142.08----
------
------
------
------
------
------
------
------
------
------
------
------
-5.43-5.38----
-5.43-5.38----
-5.30-5.24----
-5.43-5.38----
8.839.21----
-1.45-3.180.00-11.00-7.920.00
-1.51-3.38--11.13-8.02-